Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Freede, Margaret
NCT05480761: 7-Day Trial of Sucraid for Alleviating CSID Symptoms in Subjects With Low, Moderate, and Normal Sucrase Levels	Recruiting	4	1100	US	Sucraid (sacrosidase) Oral Solution 8500 IU/mL, Sucraid, Sacrosidase	QOL Medical, LLC	Congenital Sucrase-Isomaltase Deficiency, CSID, Sucrase Isomaltase Deficiency	08/24	12/24
Shambayati, Maryam
NCT05480761: 7-Day Trial of Sucraid for Alleviating CSID Symptoms in Subjects With Low, Moderate, and Normal Sucrase Levels	Recruiting	4	1100	US	Sucraid (sacrosidase) Oral Solution 8500 IU/mL, Sucraid, Sacrosidase	QOL Medical, LLC	Congenital Sucrase-Isomaltase Deficiency, CSID, Sucrase Isomaltase Deficiency	08/24	12/24
NCT02616302 / 2014-004506-15: A Study of Dexlansoprazole Delayed-Release Capsules to Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children	Recruiting	2	70	Europe, Canada, US, RoW	Dexlansoprazole, Dexilant	Takeda	Gastroesophageal Reflux Disease (GERD)	01/25	01/25
NCT02615184 / 2014-004507-73: A Study of Dexlansoprazole in Healing and Maintenance of Healed Erosive Esophagitis (EE) in Children	Recruiting	2	76	Europe, Canada, US, RoW	Dexlansoprazole, Dexilant	Takeda	Erosive Esophagitis	11/27	11/27
Weir, Valerie
NCT05480761: 7-Day Trial of Sucraid for Alleviating CSID Symptoms in Subjects With Low, Moderate, and Normal Sucrase Levels	Recruiting	4	1100	US	Sucraid (sacrosidase) Oral Solution 8500 IU/mL, Sucraid, Sacrosidase	QOL Medical, LLC	Congenital Sucrase-Isomaltase Deficiency, CSID, Sucrase Isomaltase Deficiency	08/24	12/24